Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 4;15(10):e46452.
doi: 10.7759/cureus.46452. eCollection 2023 Oct.

Identifying Clinical and Genetic Characteristics of Spinal Muscular Atrophy Patients and Families in Saudi Arabia

Affiliations

Identifying Clinical and Genetic Characteristics of Spinal Muscular Atrophy Patients and Families in Saudi Arabia

Alaa Alghamdi et al. Cureus. .

Abstract

Introduction: Spinal muscular atrophy (SMA) is an inherited, neuromuscular disease characterized by the deterioration of spinal motor neurons, causing progressive muscular atrophy and weakening. It is an autosomal recessive disease with the mutation of the survival motor neuron 1 (SMN1) gene as a hallmark. Evidence suggests that the SMN2 gene modulates the severity of the disease. SMA is classified based on the maximum motor function achieved. This study aims to describe the genetic makeup and characteristics of an SMA cohort in the Kingdom of Saudi Arabia (KSA).

Methods: Data from families presenting with SMA children was collected between January 2018 and December 2020. Blood samples were collected from patients and family members. Genetic testing for SMA and mutations was performed at a European central lab.

Results and discussion: Seventeen families were enrolled in the study, including 52 children. Among 34 parents, 28 were carriers with heterozygous deletion (82.3%), one (2.9%) had no deletion detected by multiplex ligation-dependent probe amplification (MLPA) but had point mutation by sequencing, one (2.9%) had homozygous deletion and was symptomatic, three (8.8%) had no deletion or point mutation and were presumed to have 2+0, and one (2.9%) was not tested.

Conclusion: This study provides insight into the carrier mutational analysis of families with SMA disease manifestations in KSA. Further studies are needed to understand the burden and impact of SMA among the Saudi population.

Keywords: carriers; case series; kingdom of saudi arabia (ksa); mutation; sma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Percentage of spinal muscular atrophy disease type prognosis
SMA: Spinal muscular atrophy.
Figure 2
Figure 2. Silent carrier (2+0) of two copies of SMA1 on a single chromosome and silent carriers with one copy of SMA1 on both chromosomes with an intragenic mutation in one copy
SMN1: Survival motor neuron 1; SMA: Spinal muscular atrophy.

References

    1. Genomic variability in the survival motor neuron genes (SMN1 and SMN2): implications for spinal muscular atrophy phenotype and therapeutics development. Butchbach ME. http://10.3390/ijms22157896. Int J Mol Sci. 2021;22:7896. - PMC - PubMed
    1. Spinal muscular atrophy. D'Amico A, Mercuri E, Tiziano FD, Bertini E. Orphanet J Rare Dis. 2011;6:71. - PMC - PubMed
    1. Gene therapy for spinal muscular atrophy: the Qatari experience. Ali HG, Ibrahim K, Elsaid MF, et al. Gene Ther. 2021;28:676–680. - PMC - PubMed
    1. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Wirth B, Herz M, Wetter A, et al. Am J Hum Genet. 1999;64:1340–1356. - PMC - PubMed
    1. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Calucho M, Bernal S, Alías L, et al. Neuromuscul Disord. 2018;28:208–215. - PubMed

LinkOut - more resources